Greg Madison - Net Worth and Insider Trading

Greg Madison Net Worth

The estimated net worth of Greg Madison is at least $1 Million dollars as of 2024-04-23. Greg Madison is the President and CEO of Keryx Biopharmaceuticals Inc and owns about 414,086 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $1 Million. Details can be seen in Greg Madison's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Greg Madison has not made any transactions after 2018-02-15 and currently still holds the listed stock(s).

Transaction Summary of Greg Madison

To

Greg Madison Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Greg Madison owns 2 companies in total, including Keryx Biopharmaceuticals Inc (KERX) , and AMAG Pharmaceuticals Inc (AMAG) .

Click here to see the complete history of Greg Madison’s form 4 insider trades.

Insider Ownership Summary of Greg Madison

Ticker Comapny Transaction Date Type of Owner
KERX Keryx Biopharmaceuticals Inc 2018-03-20 director & President and CEO
AMAG AMAG Pharmaceuticals Inc 2013-02-28 EVP & Chief Commercial Officer

Greg Madison Latest Holdings Summary

Greg Madison currently owns a total of 1 stock. Greg Madison owns 414,086 shares of Keryx Biopharmaceuticals Inc (KERX) as of February 15, 2018, with a value of $1 Million.

Latest Holdings of Greg Madison

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KERX Keryx Biopharmaceuticals Inc 2018-02-15 414,086 3.36 1,391,329

Holding Weightings of Greg Madison


Greg Madison Form 4 Trading Tracker

According to the SEC Form 4 filings, Greg Madison has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 15,318 shares on February 15, 2018, which brought Greg Madison around $73,680.

Insider Trading History of Greg Madison

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Greg Madison Trading Performance

GuruFocus tracks the stock performance after each of Greg Madison's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Greg Madison is -14.08%. GuruFocus also compares Greg Madison's trading performance to market benchmark return within the same time period. The performance of stocks bought by Greg Madison within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Greg Madison's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Greg Madison

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.25 -14.08 -48.2 -39.94 -14.09 -22.03
Relative Return to S&P 500(%) -11.56 -15.92 -41.69 -41.86 -22.22 -32.81

Greg Madison Ownership Network

Ownership Network List of Greg Madison

No Data

Ownership Network Relation of Greg Madison


Greg Madison Owned Company Details

What does Keryx Biopharmaceuticals Inc do?

Who are the key executives at Keryx Biopharmaceuticals Inc?

Greg Madison is the director & President and CEO of Keryx Biopharmaceuticals Inc. Other key executives at Keryx Biopharmaceuticals Inc include director & Interim CEO Jodie Pope Morrison , Chief Financial Officer Scott A Holmes , and 10 percent owner Seth A Klarman .

Keryx Biopharmaceuticals Inc (KERX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Keryx Biopharmaceuticals Inc (KERX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Keryx Biopharmaceuticals Inc (KERX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Keryx Biopharmaceuticals Inc (KERX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Keryx Biopharmaceuticals Inc Insider Transactions

No Available Data

Greg Madison Mailing Address

Above is the net worth, insider trading, and ownership report for Greg Madison. You might contact Greg Madison via mailing address: One Marina Park Drive Lexington Ma 02210.

Discussions on Greg Madison

No discussions yet.